is bydureon a semaglutide vs. Other GLP-1 Receptor Agonists Semaglutide (Wegovy®)

Marketing thrives on urgency

Liraglutide has been approved by FDA for mitigating cardiovascular disease (CVD) risks in patients with type 2 diabetes (T2D)

When to speak to your GP If you experience dizziness, lightheadedness, or fainting after starting Wegovy, your blood pressure medication may need adjusting If your home blood pressure readings are consistently below 90/60 mmHg If you experience a resting heart rate persistently above 100 bpm If gastrointestinal side effects (nausea, vomiting, diarrhoea) are severe or persistent, particularly if youre taking diuretics If youre concerned about any new symptoms after starting Wegovy Frequently asked questions Will Wegovy lower my blood pressure

Rather than focusing only on calorie reduction, established medical sources emphasize maintaining muscle, supporting recovery, and sustaining physical function during weight loss

Results: GLP-1RAs attenuate inflammation by suppressing NF-B and p38 MAPK pathways, reduce oxidative stress, enhance insulin sensitivity, and promote mitochondrial and endothelial stability

The graphical abstract was created using BioRender